These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7655497)

  • 1. Portal hypertension associated with anticardiolipin antibodies in a case of systemic lupus erythematosus.
    Takahaski C; Kumagai S; Tsubata R; Sorachi K; Ozaki S; Imura H; Nakao K
    Lupus; 1995 Jun; 4(3):232-5. PubMed ID: 7655497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
    Naarendorp M; Spiera H
    J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic portal hypertension associated with systemic lupus erythematosus.
    Inagaki H; Nonami T; Kawagoe T; Miwa T; Hosono J; Kurokawa T; Harada A; Nakao A; Takagi H; Suzuki H; Sakamoto J
    J Gastroenterol; 2000; 35(3):235-9. PubMed ID: 10755694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies.
    De Clerck LS; Michielsen PP; Ramael MR; Janssens E; Van Maercke YM; Van Marck EA; Stevens WJ
    J Rheumatol; 1991 Dec; 18(12):1919-21. PubMed ID: 1795332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
    Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticardiolipin antibodies and cardiac involvement in systemic lupus erythematosus].
    Straburzyńska-Migaj E; Klama K; Leszczyński P; Szyszka A; Mitkowski P; Łacki J; Cieśliński A
    Pol Arch Med Wewn; 2002 Mar; 107(3):231-5. PubMed ID: 12107981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
    Rodriguez VE; Gonzalez-Pares EN; Rivera C
    P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Echocardiographic changes and anticardiolipin antibodies in patients with systemic lupus erythematosus].
    Zhang SD; Wu M; Chen F; Zuo XX; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):692-5. PubMed ID: 17062932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome.
    Tubach F; Hayem G; Marchand JL; Weber M; Palazzo E; de Bandt M; Roux S; Kahn MF; Meyer O
    J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cardiolipin antibodies in HIV infection are true antiphospholipids not associated with antiphospholipid syndrome.
    Falco M; Sorrenti A; Priori R; Luan FL; Pittoni V; Agresti MG; Valesini G
    Ann Ital Med Int; 1993; 8(3):171-4. PubMed ID: 8217481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
    Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.